FIELD: medicine; pharmaceuticals.
SUBSTANCE: present invention relates to medicine, namely to pharmaceutical parenteral and ophthalmic compositions, and discloses a liquid dosage form comprising a suspension containing a hydrophobic drug substance bound to polymer nanoparticles from biodegradable polylactic acid copolymers.
EFFECT: liquid dosage form is characterized in that polymer particles are formed as a result of the destruction of the composite silica gel previously prepared from tetraethoxysilane.
4 cl, 1 dwg, 11 ex, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
INTERPOLYMER MATERIAL FOR MEDICAL AND VETERINARY USE AND PROLONGED MEDICINAL AND VETERINARY AGENTS ON ITS BASIS | 2017 |
|
RU2684608C1 |
INTERPOLYMER POLYELECTROLYTE COMPLEX AND A PROLONGED IMMUNOSTIMULATING AGENT ON ITS BASIS, FOR MEDICAL AND VETERINARY USE | 2017 |
|
RU2683947C1 |
POLYMERIC MATERIAL OF MEDICAL PURPOSE FOR EMBOLIZATION | 2017 |
|
RU2669801C1 |
OPHTHALMOLOGIC GEL OF TAURINE | 2016 |
|
RU2623205C1 |
METHOD FOR PRODUCING MICROSPHERES FOR PREPARING INJECTABLE DOSAGE FORM OF DICLOFENAC, COMPOSITION AND DOSAGE FORM | 2013 |
|
RU2524649C1 |
OPHTHALMIC PREPARATION PRESENTED IN FORM OF EYE DROPS AND CONTAINING BRANCHED POLYHEXAMETHYLENE GUANIDINES | 2012 |
|
RU2510264C1 |
OPHTHALMIC PREPARATION IN THE FORM OF EYE DROPS FOR PREVENTING AND TREATING INFECTIOUS CONJUNCTIVITIS CAUSED BY BACTERIA AND VIRUSES | 2019 |
|
RU2699377C1 |
TEST SYSTEM BASED ON CONJUGATES “POLYMERIC MICROSPHERE-THYROGLOBULIN” FOR EXPRESS DIAGNOSTICS OF AUTOIMMUNE THYROID DISORDERS | 2017 |
|
RU2657834C1 |
SOLID DOSAGE FORM OF TAURINE WITH IMPROVED PHARMACOLOGICAL PROPERTIES | 2012 |
|
RU2495663C1 |
ANTIPARASITIC COMPOSITION FOR PROTECTING AGRICULTURAL ANIMALS | 2017 |
|
RU2659174C1 |
Authors
Dates
2018-04-04—Published
2016-10-24—Filed